Skip to main content

First Genetic Trust Closing on $5.5 Million Series C Financing

NEW YORK, Sept. 24 (GenomeWeb News) -- First Genetic Trust today announced the closing of a $5.5 million Series C round of financing.

 

The venture capital firms of Venrock Associates of New York and ARCH Venture Partners of Chicago led the funding for the Deefield, Ill.-based information technology firm that offers security products and services for genetic data. Additional investors include Cooper Hill Partners of New York, a healthcare investor, and the development and services firm, Quintiles Transnational of Durham, NC.

 

First Genetic Trust took a $15.6 million first round of financing on Sept. 30, 2000, and followed with a $12.2 million round in February 2001.

 

The funds raised will support further commercialization of the Company's enTRUST genetic study and banking technology into the pharmaceutical, academic and government markets, First Genetic Trust said in a statement.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.